US EditionFDA Approves New Generic Abortion Pill as Lawsuit Moves to Missouri
The FDA approved a new generic mifepristone pill to expand access amid ongoing political and legal challenges, with medication abortions now comprising nearly two-thirds of U.S. abortions.
- On Tuesday, the U.S. Food and Drug Administration quietly approved a new generic mifepristone from Evita Solutions, approved for use through 10 weeks.
- Evita filed its application four years earlier, and federal law requires the FDA to approve generics shown bioequivalent under the Hatch‑Waxman Act.
- Conservative critics including Sen. Josh Hawley and Students for Life Action blasted the approval Thursday, while Reproductive Freedom for All's Mini Timmaraju said, `This is exactly how our system is supposed to work, and it has worked this way for decades.`
- Medication abortions account for nearly two-thirds of U.S. abortions, but access remains restricted in U.S. states with laws banning or limiting medication abortion.
- Last month, Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary, MD, MPH pledged a full safety review after 22 Republican attorneys general requested it; the EPPC study claimed almost 11% serious complications but faced criticism.
283 Articles
283 Articles
The Abortion Pill is Dangerous — Now the FDA Has Approved a Generic Version of It - CURE News and Clergy Blog
The U.S. Food and Drug Administration (FDA) last week approved a generic version of mifepristone, an abortion drug that blocks the hormone progesterone to kill the baby by starving him of nutrients. The new drug supposedly is lower cost and kills unborn babies through 10 weeks of pregnancy — but it’s no less dangerous for …
Los Angeles Times
Independent EspañolOpponents of abortion have fought against change.
FDA approval of generic abortion pill sparks criticism
LOUISVILLE, Ky. (KT) – The Federal Drug Administration (FDA) on Sept. 30 approved another generic version of mifepristone, the first pill used in a two-drug regimen to abort pregnancies through 10 weeks' gestation. Pro-life advocates are decrying the decision.
Pro-life group calls FDA’s approval of generic abortion pill ‘unconscionable’
(The Center Square) – A pro-life organization called the FDA’s approval of the generic version of the abortion drug mifepristone “unconscionable,” stating that abortion is the leading cause of death in the nation, that the abortion pill undermines states’ rights,…
FDA approves generic abortion drug, draws backlash from Republicans
The Food and Drug Administration (FDA) approved a second generic version of the abortion drug mifepristone shortly before the federal government shut down and in the face of Republican condemnation of the medication. The company that makes mifepristone, Evita Solutions, applied to make another generic form of the drug in 2021, per the FDA’s Sept. 30 approval letter. The agency typically makes its decision within 10 months, but the approval can t…
Coverage Details
Bias Distribution
- 51% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
